Northwest Biotherapeutics Inc (NASDAQ:NWBO)
| 3.68 Data as of May 23 |  +0.11 / +3.08%Today’s Change | 2.92 Today|||52-Week Range 20.00 | +17.96% Year-to-Date |
Latest NWBO News | Press Releases
No recent news for Northwest Biotherapeutics Inc.
Today’s Trading
| Previous close | 3.57 |
| Today’s open | 3.58 |
| Day’s range | -- - -- |
| Volume | 100,222 |
| Average volume (3 months) | 163,075 |
| Market cap | $107.5M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/23/2013
Growth & Valuation
| Earnings growth (last year) | -2.14% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +10.00% |
| Revenue growth (last year) | +7,620.00% |
| P/E ratio | NM |
| Price/Sales | 47.52 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ACURAcura Pharmaceutical... | +0.02 | +0.85% |
| BOTABiota Pharmaceutical... | -0.11 | -2.99% |
| ATHXAthersys Inc | -0.05 | -2.69% |
| NNVCNanoViricides Inc | +0.03 | +4.38% |
Data as of 4:00pm ET, 05/23/2013
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $772.0K |
| Annual profit (last year) | -$67.3M |
| Net profit margin | -8,720.21% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Linda F. Powers |
Chief Operating Officer Anthony E. Maida, III, PhD |
Corporate headquarters Bethesda, Maryland |
Forecasts
